| Net Loss Per Share |
Note 15 – Net Loss Per ShareThe Company computes basic net loss per share using net loss attributable to the Company’s common shareholders and the weighted-average number of common shares outstanding during each period. Diluted earnings per share include shares issuable upon exercise of outstanding stock options and stock-based awards where the conversion of such instruments would be dilutive. The Company does this through the treasury stock method. The calculations presented below represent the basic and diluted net loss per share for all classes of securities.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended June 30, |
|
|
Six months ended June 30, |
|
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss from continuing operations |
|
$ |
(6,804 |
) |
|
$ |
(11,362 |
) |
|
$ |
(76,466 |
) |
|
$ |
(36,910 |
) |
|
Net loss from discontinued operations |
|
|
— |
|
|
|
(169,761 |
) |
|
|
— |
|
|
|
(169,761 |
) |
|
Less: Net loss attributable to non-controlling interests |
|
|
— |
|
|
|
(87 |
) |
|
|
— |
|
|
|
(323 |
) |
|
Net loss attributable to common shareholders |
|
$ |
(6,804 |
) |
|
$ |
(181,036 |
) |
|
$ |
(76,466 |
) |
|
$ |
(206,348 |
) |
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares outstanding - Basic |
|
|
209,342 |
|
|
|
217,338 |
|
|
|
208,671 |
|
|
|
217,057 |
|
|
Add: Weighted average unvested options and warrants outstanding |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Add: Dilutive effect of restricted units issued |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
Weighted-average shares outstanding - Diluted |
|
|
209,342 |
|
|
|
217,338 |
|
|
|
208,671 |
|
|
|
217,057 |
|
|
Net loss per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and Diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations attributable to common shareholders |
|
$ |
(0.03 |
) |
|
$ |
(0.05 |
) |
|
$ |
(0.37 |
) |
|
$ |
(0.17 |
) |
|
Discontinued operations |
|
$ |
— |
|
|
$ |
(0.78 |
) |
|
$ |
— |
|
|
$ |
(0.78 |
) |
|
Net loss attributable to common shareholders |
|
$ |
(0.03 |
) |
|
$ |
(0.83 |
) |
|
$ |
(0.37 |
) |
|
$ |
(0.95 |
) |
|
For the three and six months ended June 30, 2026 and 2025, the Company was in a net loss position, thus the effect of potentially dilutive securities was excluded from the denominator for the calculation of diluted net loss per share because the inclusion of such securities would be antidilutive. The following dilutive securities are excluded from the denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months ended June 30, |
|
|
For the six months ended June 30, |
|
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
|
Unvested or unexercised option awards |
|
|
298,334 |
|
|
|
1,834,266 |
|
|
|
298,334 |
|
|
|
1,915,296 |
|
|
Unvested RSUs |
|
|
4,722,348 |
|
|
|
10,868,541 |
|
|
|
4,817,519 |
|
|
|
11,873,447 |
|
|
Warrants |
|
|
29,242,103 |
|
|
|
33,680,126 |
|
|
|
29,242,103 |
|
|
|
34,248,876 |
|
|
Total |
|
|
34,262,785 |
|
|
|
46,382,933 |
|
|
|
34,357,956 |
|
|
|
48,037,619 |
|
|
|